Search results
Results from the WOW.Com Content Network
These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara ...
Late last year, the Centers for Medicare & Medicaid Services announced it had reached pricing deals with companies for 10 drugs in the inaugural round of negotiations. Under the new deals, list ...
The 15 drugs accounted for $41 billion, or 14%, of total Medicare Part D spending between Nov. 1, 2023, and Oct. 1, 2024.
This is a list of insurance companies based in the United States. These are companies with a strong national or regional presence, having insurance as their primary business. History
Aflac has appeared on Fortune's 100 Best Companies to Work For list for 20 consecutive years. [citation needed] As of 2020, Aflac had appeared on Fortune's America's Most Admired Companies list for 19 years. [39] Aflac has been recognized by Ethisphere magazine as a World's Most Ethical Company since 2007. [40]
340B DSH hospitals provide nearly twice as much care as non-340B hospitals – 41.9 percent versus 22.8 percent – to Medicaid beneficiaries and low-income Medicare patients. 340B hospitals provide 40 percent more uncompensated care as a percent of total patient care costs than non-340B hospitals – $24.6 billion to $17.5 billion.
Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on out-of-pocket payments from the Inflation Reduction Act goes into effect.
In January 2007, the 110th United States House of Representatives approved H.R. 4, the Medicare Prescription Drug Price Negotiation Act, [1] a bill to require federal officials to negotiate with drug companies for lower prices for the 23 million senior citizens who have signed up for Medicare's prescription drug coverage. The bill was never ...